Pseudomonas aeruginosa is an environmental organism found in soil and water that can infect humans, and multidrug-resistant forms show resistance to many antibiotics, complicating treatment [1]. MDR P. aeruginosa is a particularly hard-to-treat resistant variant able to invade bloodstream, lung, urinary, wound, or surgical sites [1].
Aperçu de la maladie
BactérienneInfection à Pseudomonas aeruginosa multirésistante
Multidrug-resistant Pseudomonas aeruginosa infection
Suivre cette maladie Comparer les paysMultidrug-resistant Pseudomonas aeruginosa is a difficult-to-treat environmental bacterium capable of causing serious infections in humans and is recognized as a global priority pathogen [1][2]. In the United States, an estimated 32,600 infections and 2,700 deaths occurred among hospitalized patients in 2017 [1]. Healthcare-associated exposure and device use are central to its public-health impact [1].
Lire le profil clinique et épidémiologique complet 6
Infections may involve the bloodstream, lungs, urinary tract, wounds, or surgical sites after operative procedures [1]. The resistant phenotype limits routine therapeutic options and necessitates susceptibility-guided management [1][2].
The infection predominantly arises in healthcare environments, with elevated occurrence among patients using ventilators or catheters and those with surgical wounds or burns [1]. In 2017, MDR P. aeruginosa accounted for an estimated 32,600 infections and 2,700 deaths in hospitalized U.S. patients [1].
Exposure can occur through contaminated surfaces, medical equipment, soil, water, or the hands of personnel [1]. Within facilities, device-associated and wound or burn care pathways represent key routes of acquisition [1].
Hand hygiene together with core infection-prevention and control practices forms the foundation of risk reduction [1]. Environmental cleaning and healthcare water-management programs further limit contamination sources [1].
- 1 US Centers for Disease Control and Prevention. About Pseudomonas aeruginosa | P. aeruginosa | CDC [Internet]. cited 23 Oct 2026. Available from: https://www.cdc.gov/pseudomonas-aeruginosa/about/index.html
- 2 Macesic N et al. Multidrug-resistant Gram-negative bacterial infections. Lancet. 2025 Jan 18. PMID: 39826970. doi: 10.1016/S0140-6736(24)02081-6. PubMed: https://pubmed.ncbi.nlm.nih.gov/39826970/
- 3 Bassetti M et al. New antibiotics for Gram-negative pneumonia. Eur Respir Rev. 2022 Dec 31. PMID: 36543346. doi: 10.1183/16000617.0119-2022. PubMed: https://pubmed.ncbi.nlm.nih.gov/36543346/
Chargement des données actuelles…
Tendances nationales
Choisissez le pays, la source et la mesure ; chaque courbe conserve sa période et sa définition de déclaration.
Couverture des données
Pays et régions déclarants
La carte montre la couverture déclarée. Choisissez une mesure ou ouvrez un lieu coloré pour consulter ses données.
Chargement des données actuelles…
Profil de surveillance
Saisonnalité du pays sélectionné
Consultez les valeurs mensuelles d’un pays par année. Les cases vides indiquent une valeur non publiée.
Chargement des alertes officielles…
Téléchargement et méthodes
Choisissez une période et téléchargez les fichiers CSV, JSON ou XLSX.

